Why this matters early
Regulatory context and integration strategy should be early product decisions, not late implementation details. In Canada, Health Canada pathway assumptions, intended use wording, and risk framing can influence architecture, evidence strategy, and timeline from the beginning.
What this page helps you decide
This page helps teams connect product positioning to regulatory and ecosystem strategy. The same software can create a different planning burden depending on intended use, claims, clinical context, user role, integration depth, and evidence expectations.
Use it early, before marketing language, pitch decks, pilot scope, or architecture choices make the product harder to reposition.
Health Canada context for non-experts
At a practical level, teams should define what the product does, what clinical claims it makes, and how risk is controlled. This clarity improves conversations with regulatory advisors and reduces rework. If claims are unclear, development can move fast in the wrong direction.
Use this with your quality plan and risk process so technical execution and regulatory expectations stay aligned.
Three early artifacts
You do not need a complete submission strategy before building, but you do need enough clarity to avoid building against the wrong assumptions. Start with three simple artifacts and expect them to evolve with qualified regulatory input.
- Intended-use draft: what the product does, for whom, in what setting, and for what decision or workflow.
- Claim boundary: what the product will and will not claim in the first pilot or release.
- Evidence map: what data, testing, validation, and risk controls would support those claims.
Standalone vs integrated ecosystem strategy
| Approach | Benefits | Challenges |
|---|---|---|
| Standalone product | Faster control over roadmap and release cycle. | Adoption may be slower if workflows already depend on existing systems. |
| EMR/EHR integrated | Better workflow fit and data continuity for users. | Higher integration complexity, approvals, and implementation effort. |
| Phased strategy | Start standalone, integrate later based on validated demand. | Requires clear architecture planning to avoid expensive rewrite. |
Founder decision points
- What is the minimum claim set needed for your first deployment?
- Does your target customer require EMR integration at pilot stage, or later?
- Can your team support integration timelines and maintenance overhead?
- How will regulatory and integration decisions affect cost and staffing?
Official references
Curriculum page last reviewed: 2026-04-22.
Summaries are for learning only; confirm licensing, classification, and evidence with qualified regulatory advisors.
Practical next step
Write a first intended-use draft and a separate claim boundary list that states what the first pilot will not claim.
- Template or worksheet: assumption and decision log template.
- Glossary terms: indications for use, SaMD, validation.
- Pathway links: FDA pathways, Design controls.